Gad experienced a negative side effect While the initial GLP-1 agonist Gad was using helped him lose weight, he said he ultimately had to stop taking it and switch to a different one due to a side effect
The training focuses on foundational concepts in weight management science and evidence-based practice to build knowledge, skills, and competence in pediatric and adult populations
Both semaglutide and tirzepatide are long-acting GLP-1 medications, meaning they stay active in your system for several days, helping to regulate appetite, improve insulin function, and support weight loss all week long
They are not for human consumption, veterinary use, or medical applications
Sermorelin remains used in some dynamic GH stimulation tests in pediatric endocrinology, but this is a historical clinical use rather than a reference in preclinical research